2m 2m 2m 2m 2m 2m 2m
20/20 BIOLABS (AIDX)
NASDAQ
$0.25+$0.0003 (+0.12%)
Price as of Oct 22, 2026 4:00 PM EDT- $3.5MMarket Cap
- N/A1-Year Change
- Medical DevicesIndustry
20/20 BIOLABS (AIDX)
$0.25+$0.0003 (+0.12%)
AIDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.25 | ||
Change | -$0.02 (-7.22%) | ||
Open | $0.27 | ||
High | $0.27 | ||
Low | $0.25 | ||
Previous Close | $0.27 | ||
Volume | 128,932 | ||
30-Day Average Volume | 121,020 | ||
1-Week Change | -8.87% | ||
1-Month Change | -46.72% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $6.1M | ||
Market Cap | $3.5M | ||
Enterprise Value | -$747,740.00 | ||
Period: QTR TTM FY | |||
Revenue | $730,571.00 | ||
Net Income | -$2.8M | ||
Free Cash Flow | -$605,460.00 | ||
EBIT | -$2.8M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $2.5M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -1 | ||
P/B | 2 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue